Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease

By Tapan Serkan   Dogru Teoman   Kara Muammer   Ercin C Nuri   Kilciler Guldem   Genc Halil   Sertoglu Erdim   Acikel Cengizhan   Kilic Selim   Karslioglu Yildirim   Kurt Ismail   Erbil Mehmet K.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 6, 2010-10 ,pp. : 399-403

Informa Healthcare

Access to resources Recommend Favorite

Plantago ovata fibre smooths out peaks without interfering with blood levels of levodopa in patients with Parkinson's disease

By  

FOCUS ON ALTERNATIVE AND COMPLEMENTARY THERAPIES AN EVIDENCE-BASED APPROACH, Vol. 20, Iss. 1, 2015-03 ,pp. : 46-47

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct Effect of Subthalamic Nucleus Stimulation on Levodopa-Induced Peak-Dose Dyskinesia in Patients with Parkinson’s Disease

By  

Stereotactic and Functional Neurosurgery, Vol. 84, Iss. 4, 2006-09 ,pp. : 176-179

Karger

Access to resources Recommend Favorite

Effect of opicapone on levodopa pharmacokinetics, catechol‐O‐methyltransferase activity and motor fluctuations in patients with Parkinson's disease

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 815-e56

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin 6(-174G/C) Variant and its Circulating Levels in Coronary Artery Disease Patients and Their First Degree Relatives

By Galimudi Rajesh   Spurthi Mrudula   Padala Chiranjeevi   Kumar Kishore   Mudigonda Saraswati   Reddy Srilatha   Aiyengar Mohini   Sahu Sanjib   Rani Surekha  

Inflammation, Vol. 37, Iss. 2, 2014-04 ,pp. : 314-321

Springer Publishing Company

Access to resources Recommend Favorite